Bone Biologics Corp (BBLGW) Short term Debt (2013 - 2017)
Bone Biologics (BBLGW) posted quarterly Short term Debt of $12.9 million for Q3 2017, up 43.33% year-over-year from $9.0 million in Q3 2016, and up 5.74% quarter-over-quarter from $12.2 million in Q2 2017.
Bone Biologics Corp (BBLGW) Short term Debt (2013 - 2017) Analysis & Trends
Bone Biologics (BBLGW) has reported Short term Debt for 5 consecutive years, with $12.9 million the latest figure, recorded in Q3 2017.
- In Q3 2017, Short term Debt rose 43.33% year-over-year to $12.9 million; the TTM figure through Sep 2017 stood at $12.9 million (up 43.33% YoY), while the FY2016 annual figure was $1.2 million, down 82.86% from the prior year.
- Short term Debt grew to $12.9 million in Q3 2017 per BBLGW's latest filing, from $12.2 million in the prior quarter.
- Across five years, Short term Debt topped out at $12.9 million in Q3 2017 and bottomed at $41300.0 in Q4 2013.
- Historically, Short term Debt has averaged $6.9 million across 5 years, with a median of $7.0 million in 2015.
- Annual changes were most pronounced in 2014 — Short term Debt jumped 12006.54% — and 2016, when it sank 82.86%.
- Bone Biologics' Short term Debt stood at $41300.0 in 2013, then surged by 12006.54% to $5.0 million in 2014, then jumped by 40.0% to $7.0 million in 2015, then tumbled by 82.86% to $1.2 million in 2016, then jumped by 975.0% to $12.9 million in 2017.
- Business Quant data shows BBLGW's Short term Debt at $12.9 million in Q3 2017, $12.2 million in Q2 2017, and $12.2 million in Q1 2017.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | 12.90 Mn |
| Jun 30, 2017 | 12.20 Mn |
| Mar 31, 2017 | 12.20 Mn |
| Dec 31, 2016 | 1.20 Mn |
| Sep 30, 2016 | 9.00 Mn |
| Jun 30, 2016 | 9.00 Mn |
| Mar 31, 2016 | 9.00 Mn |
| Dec 31, 2015 | 7.00 Mn |
| Sep 30, 2015 | 7.00 Mn |
| Jun 30, 2015 | 5.00 Mn |
| Dec 31, 2014 | 5.00 Mn |
| Sep 30, 2014 | 140,175.00 |
| Dec 31, 2013 | 41,300.00 |